MaxCyte Stock Forward View - Simple Regression
| MXCT Stock | USD 0.77 0.02 2.67% |
The Simple Regression forecast reference data for MaxCyte is based on the equity's recent trading history. This page summarizes the model output and key accuracy metrics for reference.
The Simple Regression forecasted value of MaxCyte on the next trading day is expected to be 0.53 with a mean absolute deviation of 0.12 and the sum of the absolute errors of 7.64.In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as MaxCyte historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data. All Simple Regression forecast figures shown for MaxCyte are reference data reflecting model output based on available historical prices. Simple Regression Price Forecast For the 22nd of March
Given 90 days horizon, the Simple Regression forecasted value of MaxCyte on the next trading day is expected to be 0.53 with a mean absolute deviation of 0.12 , mean absolute percentage error of 0.02 , and the sum of the absolute errors of 7.64 .Please note that although there have been many attempts to predict MaxCyte Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that MaxCyte's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest MaxCyte | MaxCyte Price Prediction | Research Analysis |
Forecasted Value
The next-day forecast for MaxCyte focuses on identifying predictive downside and upside bands that can frame a realistic trading range. At the moment, the model places downside around 0.01 and upside around 4.20 for the forecasting period.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of MaxCyte stock data series using in forecasting. Note that when a statistical model is used to represent MaxCyte stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.0798 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1233 |
| MAPE | Mean absolute percentage error | 0.1377 |
| SAE | Sum of the absolute errors | 7.6442 |
Other Forecasting Options for MaxCyte
Whether a novice or experienced investor, anyone considering MaxCyte needs to understand the dynamics of MaxCyte's price movement. Price charts for MaxCyte Stock contain a significant amount of noise that can distort investment decisions.MaxCyte Related Equities
The following equities are related to MaxCyte within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing MaxCyte against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
MaxCyte Market Strength Events
Analyzing market strength indicators for MaxCyte enables investors to understand how the stock performs relative to overall market momentum. These indicators are valuable tools for identifying when to enter or exit positions in MaxCyte.
| Accumulation Distribution | 59950.51 | |||
| Daily Balance Of Power | 0.4 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 0.76 | |||
| Day Typical Price | 0.76 | |||
| Price Action Indicator | 0.025 | |||
| Period Momentum Indicator | 0.02 |
MaxCyte Risk Indicators
Identifying and analyzing MaxCyte's key risk indicators is a foundational step in projecting how its price may evolve. This process quantifies the risk associated with MaxCyte's and decide how to manage it.
| Mean Deviation | 2.93 | |||
| Standard Deviation | 3.75 | |||
| Variance | 14.09 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for MaxCyte
The amount of media and story coverage tied to MaxCyte can signal where market attention is concentrating at the moment. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Contributor Headline
Latest Perspective From Macroaxis
MaxCyte Short Properties
Short sentiment tied to MaxCyte matters because heavier bearish pressure can change how quickly future price expectations become unstable. This is most valuable when investors want to know whether bearish pressure is starting to shape the market's reaction function.
| Common Stock Shares Outstanding | 104.8 M | |
| Cash And Short Term Investments | 154.5 M |
Additional Tools for MaxCyte Stock Analysis
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |